April Ehlers
Medical · Lubbock, TXNPI 1639574957
Payments from drug & device makers
Across 502 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Lilly USA, LLC$1K
- Pfizer$830
- GSK$620
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$606
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,638100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 97 | $1,473 |
| AstraZeneca | 60 | $1,157 |
| Lilly USA, LLC | 70 | $1,109 |
| Pfizer | 44 | $830 |
| GSK | 38 | $620 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 32 | $606 |
| Abbott | 25 | $407 |
| Bayer | 17 | $332 |
| Astellas Pharma US Inc | 14 | $295 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $275 |
| Exact Sciences | 15 | $255 |
| Biohaven Pharmaceuticals, Inc. | 10 | $209 |
| E.r. Squibb & Sons, L.L.C. | 12 | $203 |
| Boehringer Ingelheim | 11 | $195 |
| Esperion Therapeutics, Inc. | 6 | $95 |
| Novo Nordisk | 5 | $89 |
| Novartis | 4 | $71 |
| Amgen | 4 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Genentech USA, Inc. | 2 | $37 |
| Boston Scientific | 1 | $32 |
| Merck | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Lundbeck LLC | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| BD | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
How this compares
$8,647 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $13,857 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $1,967 |
| Azithromycin | 108 | $920 |
| Alprazolam | 109 | $685 |
| Trazodone Hcl | 31 | $442 |
| Rosuvastatin Calcium | 30 | $435 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $421 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $415 |
| Doxycycline Hyclate | 46 | $412 |
| Omeprazole | 36 | $403 |
| Azelastine Hcl | 12 | $396 |
| Oseltamivir Phosphate | 25 | $392 |
| Ezetimibe | 26 | $353 |
| Simvastatin | 35 | $341 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $335 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere | $1,157 | $13,85716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,490 medical providers in Texas.
Other medical in Lubbock
- Lauren WheelerLubbock$25K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.